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We report here a case of multiple pedunculated poro-
mas in a patient with rheumatoid arthritis treated with 
methotrexate.
CASE REPORT
A 76-year-old Japanese woman was referred to our clinic for eval-
uation of a 3-year history of multiple reddish nodules. She had 
a medical history of breast cancer 12 years previously. She had 
also been treated for 4 years with oral methotrexate (8 mg/week) 
for rheumatoid arthritis. Physical examination revealed multiple 
pedunculated nodules, approximately 4–5 mm in diameter, on both 
hands, face and trunk (4 nodules in total) (Fig. 1). The tumours 
were suspected to be pyogenic granulomas or skin tags, and were 
resected under local anaesthesia. Histopathologically, the entire 
tumour consisted of broad, anastomozing bands connected to 
the epidermis in a polypoid fashion (Fig. 2a). Tumour cells were 
composed of cuboidal poroid cells and eosinophilic cuticular cells. 
Small ductal structures were also seen (Fig. 2b). The tumour stroma 
was rich in vessels and eosinophilic hyalinized collagen (Fig. 2c). 
Based on these findings, a diagnosis of poromatosis in association 
with methotrexate treatment was made.
DISCUSSION
Poroma is a relatively common adnexal neoplasm that 
presents as a dome-shaped nodule in areas with abundant 
eccrine sweat glands. It occasionally occurs as multiple 
lesions, known as poromatosis. Although its pathogenesis 
remains to be elucidated, most cases of multiple poro-
mas occur in patients who have received radiotherapy 
or cancer chemotherapy (1–15). An immunosuppres-
sive condition might be involved in the development of 
multiple poromas. We reviewed previous reports on cases 
of multiple poromas related to medical treatment (Table 
I). Men accounted for 75% of patients. The tumours 
arose not only on the hands or feet, but also on the trunk 
and face. Eighteen (90%) of 20 cases had underlying 
neoplasms, especially haematological malignancies. 
Interest ingly, the tumour in 13 cases (65%) had a poly-
poidal appearance. In addition, multiple polypoidal poro-
mas developed in 4 cases, including the current case, and 
these were treated with methotrexate. Cases of multiple 
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Fig. 1. A polypoidal nodule on the trunk.
Fig. 2. Histopathology of the tumour. (a) The tumour 
consisted of broad, anastomozing bands connected to the 
epidermis with a polypoid appearance (bar: 500 μm). (b) 
Tumour cells consisted of round-shaped poroid cells and 
eosinophilic cuticular cells. Small ductal structures were 
also seen (bar: 50 μm). (c) The stroma of the tumour 
was rich in vessels and eosinophilic hyalinized collagen 


























































poromas after radiation therapy without chemotherapy 
were excluded from the review because the tumours in 
those cases developed only in the irradiated region and 
did not show a pedunculated appearance (not shown). 
The current patient had been treated with methotrexate 
for rheumatoid arthritis. Methotrexate is one of the che-
motherapy agents (immunosuppressants) and is used for 
the treatment of many diseases. In addition to its well-
known various adverse reactions, the drug may have a 
direct or indirect effect on the development of pedun-
culated poromas. Although we do not why drug-induced 
proroma shows exophytic growth, it is known that 
methotrexate occasionally causes acral erythema, sug-
gesting excretion from sweat glands. An accumulation of 
methotrexate could be related to tumourigenesis. Since 
various chemotherapeutic agents were used for treat ment 
in previously reported cases, other possible drugs could 
not be identified, except methotrexate. However, some 
chemotherapeutic agents are also concentrated in eccrine 
glands, which might cause multiple polypoidal poromas. 
In conclusion, dermatologists must consider the pos-
sibility of drug involvement, especially methotrexate, in 
patients with multiple pedunculated poromas.
The authors have no conflicts of interest to declare.
REFERENCES
1. Mahlberg MJ, McGinnis KS, Draft KS, Fakhardzadeh SS. Mul-
tiple eccrine poromas in the setting of total body irradiation 
and immunosuppression. J Am Acad Dermatol 2006; 55: 
S46–S49.
2. Navi D, Fung M, Lynch PJ. Poromatosis: the occurrence of 
multiple eccrine poromas. Dermatol Online J 2008; 14: 3.
3. Sherman V, Reed J, Hollowood K, Littlewood T, Burge SM. 
Poromas and porokeratosis in a patient treated for solid-
organ and haematological malignancies. Clin Exp Dermatol 
2010; 35: e130–132.
4. Diamantis ML, Richmond HM, Rady PL, Tring SK, Cutlan JE, 
Torres-Cabala C, et al. Detection of human papillomavirus 
in multiple eccrine poromas in a patient with chronic graft-
vs-host disease and immunosuppression. Arch Dermatol 
2011; 147: 120–122.
5. Nguyen BT, Lortscher DN, Lee RA. Multiple poromas in a 
bone marrow transplant recipient: a case report. Dermatol 
Online J 2012; 18: 9.
6. Fujii K, Aochi S, Takeshima C, Ohtsukka M, Hamada T, Asagoe 
K, et al. Eccrine poromatosis associated with polychemoth-
erapy. Acta Derm Venereol 2012; 92: 687–690.
7. Deckelbaum S, Touloei K, Shibata PK, Sire DJ, Horowitz D. 
Eccrine poromatosis: case report and review of the literature. 
Int J Dermatol 2014; 53: 543–548.
8. Garshick M. Eccine poromatosis in a patient with acute my-
eloid leukemia following chemotherapy. Dermatol Online J 
2014; 20: 11.
9. Takahashi C, Nishi K, Minami-Hori M, Kishibe M, Ishida-
Yamamoto A, Iizuka H. Multiple poromas following combina-
tion chemotherapy and autologous peripheral blodd stem cell 
transplantation. J Dermatol 2015; 42: 430–432.
10. Mayo TT, Kole L, Elewski B. Eccrine poromatosis: case report, 
review of the liliterature, and treatment. Skin Appendage 
Disord 2015; 1: 95–98.
11. Aung PP, Rady PL, Nagarajan P, Ivan D, Tezlaff MT, Curry JL, 
et al. Detection of Merkel cell polyoma virus and beta hu-
man papillomavirus in multiple eccrine poromas in a patient 
with acute leukemia treated with stem cell transplant. Am J 
Dermatopathol 2017; 39: 489–491.
12. Valdebran MA, Hong C, Cha J. Multiple eruptive poromas 
associated with chemotherapy and autologous bone marrow 
transplantation. Indian Dermatol Online J 2018; 9: 259–261.
13. Lim TM, Weir J, Fearfield L. Eruptive poromatosis in a patient 
with breast cancer. J Cutan Pathol 2018; 45: 708–710.
14. Yoshii Y, Matsuo S, Nishizawa A, Satoh T. Multiple eccrine 
poromas in a patient with systemic lupus erythematosus. 
Eur J Dermatol 2018; 28: 837.
15. Nguyen K, Kim G, Chiu M. Eccrine poromatosis following 
chemotherapy and radiation therapy. Dermatol Online J 
2019; 25: 11.





n Location Underlying disease
Polypoidal 
appearance Possible cause MTX
Mahlberg et al. (1) 42 M  14 Extremities Acute lymphocytic leukaemia Radiotherapy
Chemotherapy
Navi et al. (2) 64 M  8 Face, trunk, extremities Hodgkin lymphoma Yes Chemotherapy




Diamantis et al. (4) 53 M  6 Extremities Mantle cell lymphoma Chemotherapy
Nguyen et al. (5) 25 M  8 Extremities Acute myelogenous leukaemia Chemotherapy
Fujii et al. (6) 66 F  19 Trunk, extremities Chronic lymphocytic leukaemia Yes Radiotherapy
Chemotherapy
Yes
62 M  3 Extremities Malignant fibrous histiocytoma Yes Radiotherapy
Chemotherapy
59 M  4 Extremities B cell lymphoma Yes Chemotherapy Yes
72 M > 5 Trunk, extremities Diffuse large B cell lymphoma Yes Chemotherapy
Deckelbaum et al (7) 42 M  30 Extremities Testicular lymphoma Radiotherapy
Chemotherapy
Garshik (8) 46 M  22 Extremities Acute myeloid leukaemia Yes Chemotherapy
Takahashi et al. (9) 63 F    5 Trunk, extremities Acute myelocytic leukaemia Yes Chemotherapy
Mayo et al (10) 43 M  16 Extremities Mantle cell lymphoma Yes Chemotherapy Yes
Aung et al. (11) 45 M    3 Extremities Acute myeloid leukaemia Chemotherapy
Valdebran et al. (12) 32 F  17 Face, extremities Acute promyelocytic leukaemia Chemotherapy
Lim et al. (13) 63 F  18 Head, trunk extremities Breast cancer Yes Radiotherapy
Chemotherapy
Yoshii et al. (14) 52 M  17 Face, trunk, extremities Systemic lupus erythematosus Yes Immunosuppressant
Nguyen et al. (15) 58 M  4 Trunk, extremities Diffuse large B cell lymphoma Yes Chemotherapy
72 M  2 Trunk, extremities Mantle cell lymphoma Chemotherapy
Present case 76 F  4 Face, trunk, extremities Rheumatoid arthritis Yes Immunosuppressant Yes
MTX: methotrexate; M: male; F: female.
